J
Jayshree Joshi
Researcher at Hammersmith Hospital
Publications - 20
Citations - 1581
Jayshree Joshi is an academic researcher from Hammersmith Hospital. The author has contributed to research in topics: Coronary artery disease & Hypertrophic cardiomyopathy. The author has an hindex of 9, co-authored 20 publications receiving 1496 citations.
Papers
More filters
Journal ArticleDOI
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Alicia M. Maceira,Jayshree Joshi,Sanjay K Prasad,James C. Moon,Enrica Perugini,Idris Harding,Mary N. Sheppard,Philip A. Poole-Wilson,Philip N. Hawkins,Dudley J. Pennell +9 more
TL;DR: In cardiac amyloidosis, CMR shows a characteristic pattern of global subendocardial late enhancement coupled with abnormal myocardial and blood-pool gadolinium kinetics and may prove to have value in diagnosis and treatment follow-up.
Journal ArticleDOI
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies.
TL;DR: Two-dimensional echocardiographic studies were prospectively performed in 93 patients with systemic lupus erythematosus to discover the incidence and spectrum of cardiac abnormalities and to relate these findings to the presence of high levels of anticardiolipin antibodies.
Journal ArticleDOI
Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography.
TL;DR: It is concluded that atherosclerotic lesions in the thoracic aorta can readily be identified with transesophageal echocardiographic studies, and may be used serially to investigate whether dietary or pharmacologic maneuvers, or both, can shrink established atheosclerotic plaques in the abdomen.
Journal ArticleDOI
Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.
Julian D. Gillmore,Hugh J. B. Goodman,Helen J. Lachmann,Mark Offer,Ashutosh D. Wechalekar,Jayshree Joshi,Mark B. Pepys,Philip N. Hawkins +7 more
TL;DR: Heart transplantation followed by SCT is feasible in selected patients with cardiac AL amyloidosis and may confer substantial survival benefit.
Journal ArticleDOI
The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy.
M Ryan,John G.F. Cleland,Julia A. French,Jayshree Joshi,Lubna Choudhury,Lidia Chojnowska,Eva Michalak,Sahar Al-Mahdawi,Petros Nihoyannopoulos,Celia M. Oakley +9 more
TL;DR: While echocardiography aids in the specificity of HC diagnosis, the ECG, within the context of a family with a proven case of HC, is a more sensitive marker of the disease and is therefore both a cost-effective and useful tool for screening those to proceed to echOCardiography.